Pasithea Therapeutics Corp. (KTTA): Gross Profit

Annual figures by period end, from SEC filings. For years the company left out, it is revenue minus cost of revenue, computed by TickerFacts; where both exist they agree (see each figure's source).

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

Older than the company's other figures. The latest Gross Profit is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$373.4K
Year ended 2022-12-31
2021-12-31: -$2.2K2022-12-31: $373.4K$373.4K
2021-12-31 Gross Profit (USD) 2022-12-31
Period endedGross ProfitChange YoYSource filing
2022-12-31$373.4Kn/m2023-03-30, From 2022-01-01
2021-12-31-$2.2Kn/a2022-03-30, From 2021-01-01